The Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) has been named a finalist for the 2023 Clinical Research Achievement Awards. The Clinical Research Achievement…
The Early Outpatient COVID-19 Plasma Treatment Research Study (CSSC-004) had its final results published in The New England Journal of Medicine on March 30th, 2022.…
COVID-19, the disease caused by the SARS-CoV-2 virus, began spreading in late 2019. Global health authorities quickly started tracking and studying the outbreak. By March 11, 2020, the World…